Literature DB >> 27107818

Prevalence of type 2 diabetes mellitus (T2DM) in the adult Russian population (NATION study).

Ivan Dedov1, Marina Shestakova2, Massimo Massi Benedetti3, Dominique Simon4, Iakov Pakhomov5, Gagik Galstyan6.   

Abstract

AIM: To estimate type 2 diabetes mellitus (T2DM) prevalence in Russian adults.
METHODS: NATION is a national, epidemiological, cross-sectional study, conducted in Russia. In adults (aged 20-79 years), recruitment was stratified by age, sex, geographic region and settlement type to obtain a representative sample. Recruitment was in public areas with high numbers of people. T2DM was diagnosed by glycated haemoglobin A1c (HbA1c) levels (diabetes: HbA1c ≥6.5% [≥48mmol/mol]; pre-diabetes: HbA1c ≥5.7 to <6.5% [≥39 to <48mmol/mol]). Socio-demographic and anthropometric data were collected.
RESULTS: Blood samples from 26,620 subjects were available. Overall, 5.4% were diagnosed with T2DM (previously diagnosed: 2.5%; previously undiagnosed: 2.9%); 19.3% were pre-diabetic. T2DM prevalence increased with age (up to 70 years) and was higher among females than males (6.1% vs. 4.7%, p<0.001). The estimated proportion of subjects with pre-diabetes and T2DM tended to increase with increasing body mass index. T2DM prevalence was higher in rural versus urban populations (6.7% vs. 5.0%, p<0.001).
CONCLUSION: In the Russian adult population, 19.3% had pre-diabetes, T2DM prevalence was 5.4%, and 54% of subjects with diabetes were previously undiagnosed. These results may help to develop a new T2DM predictive, preventative and management programme in Russia.
Copyright © 2016 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.

Entities:  

Keywords:  Diabetes mellitus, type 2; Epidemiological study; Prevalence; Russia; Undiagnosed diabetes mellitus

Mesh:

Substances:

Year:  2016        PMID: 27107818     DOI: 10.1016/j.diabres.2016.02.010

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  15 in total

1.  Relationship of miRNA‑126 and miRNA‑122 expression with type 2 diabetes mellitus and related glucose metabolism parameters: A systematic review and meta‑analysis.

Authors:  Yaling He; Yuqian Li; Zhihan Zhai; Pengling Liu; Luting Nie; Yiquan Zheng; Jian Hou; Wenqian Huo; Zhenxing Mao; Zhenzhong Zhang; Chongjian Wang; Xiaotian Liu
Journal:  Exp Ther Med       Date:  2022-09-05       Impact factor: 2.751

2.  Integrated computational approaches to screen gene expression data to determine key genes and therapeutic targets for type-2 diabetes mellitus.

Authors:  Fahad A Alhumaydhi
Journal:  Saudi J Biol Sci       Date:  2022-02-10       Impact factor: 4.052

3.  Lifestyle modification program, LIFE is LIGHT, in patients with type 2 diabetes mellitus and obesity: Results from a 48-week, multicenter, non-randomized, parallel-group, open-label study.

Authors:  Gagik R Galstyan; Farida V Valeeva; Svetlana I Motkova; Elena V Surkova; Larisa V Savelyeva; Larisa M Rudina; Krishnan Ramanathan; Ekaterina Sokareva; Kristina Bondareva; Marina V Shestakova
Journal:  Obes Sci Pract       Date:  2021-04-09

4.  Urban-Rural Differences in the Prevalence of Self-Reported Diabetes and its Risk Factors: The WHO STEPS Iranian Noncommunicable Disease Risk Factor Surveillance in 2011.

Authors:  Zahra Khorrami; Shahin Yarahmadi; Koorosh Etemad; Soheila Khodakarim; Mohammad Esmaeil Kameli; Ali Reza Mahdavi Hazaveh
Journal:  Iran J Med Sci       Date:  2017-09

5.  Prevalence, awareness and control of diabetes in Russia: The Ural Eye and Medical Study on adults aged 40+ years.

Authors:  Mukharram M Bikbov; Rinat R Fayzrakhmanov; Gyulli M Kazakbaeva; Rinat M Zainullin; Inga I Arslangareeva; Timur R Gilmanshin; Venera F Salavatova; Nikolai A Nikitin; Svetlana R Mukhamadieva; Dilya F Yakupova; Renat I Khikmatullin; Artur F Zaynetdinov; Yulia V Uzianbaeva; Said K Aminev; Ildar F Nuriev; Jost B Jonas
Journal:  PLoS One       Date:  2019-04-22       Impact factor: 3.240

6.  Prevalence, Awareness, Treatment, Control, and the Associated Factors of Diabetes in an Iranian Kurdish Population.

Authors:  Roya Safari-Faramani; Fatemeh Rajati; Kamran Tavakol; Behrooz Hamzeh; Yahya Pasdar; Mehdi Moradinazar; Farid Najafi
Journal:  J Diabetes Res       Date:  2019-09-03       Impact factor: 4.011

7.  Association of HLA Class I Genotypes With Severity of Coronavirus Disease-19.

Authors:  Maxim Shkurnikov; Stepan Nersisyan; Tatjana Jankevic; Alexei Galatenko; Ivan Gordeev; Valery Vechorko; Alexander Tonevitsky
Journal:  Front Immunol       Date:  2021-02-23       Impact factor: 7.561

8.  What factors explain the much higher diabetes prevalence in Russia compared with Norway? Major sex differences in the contribution of adiposity.

Authors:  Olena Iakunchykova; Maria Averina; Tom Wilsgaard; Sofia Malyutina; Alexander V Kudryavtsev; Sarah Cook; Sarah Wild; Anne Elise Eggen; Laila Arnesdatter Hopstock; David A Leon
Journal:  BMJ Open Diabetes Res Care       Date:  2021-03

9.  Incidence of type 2 diabetes mellitus and prediabetes in Kerala, India: results from a 10-year prospective cohort.

Authors:  Gadadharan Vijayakumar; Sreeja Manghat; Revathi Vijayakumar; Leena Simon; Liss Maria Scaria; Aswathi Vijayakumar; Ganapathy K Sreehari; V Raman Kutty; Arun Rachana; Abdul Jaleel
Journal:  BMC Public Health       Date:  2019-01-31       Impact factor: 3.295

10.  Enrolment Phase Results of the Tabari Cohort Study: Comparing Family History, Lipids and Anthropometric Profiles Among Diabetic Patients.

Authors:  Mahmood Moosazadeh; Mahdi Afshari; Kaveh Jafari; Motahareh Kheradmand; Zahra Kashi; Mohsen Aarabi; Adeleh Bahar; Mohammad Khademloo
Journal:  Osong Public Health Res Perspect       Date:  2019-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.